Contraception
Volume 82, Issue 3 , Pages 256-259 , September 2010

Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate

Received 4 November 2009 ,Revised 3 February 2010 ,Accepted 4 February 2010.

References 

  1. Paranjothy S, Broughton H, Adappa R, Fone D. Teenage pregnancy: who suffers?. Arch Dis Child. 2009;94(3):239–245
  2. Coley RL, Chase-Lansdale PL. Adolescent pregnancy and parenthood. Recent evidence and future directions. Am Psychol. 1998;53(2):152–166
  3. Mestad RE, Kenerson J, Peipert JF. Reversible contraception update: the importance of long-acting reversible contraception. Postgrad Med. 2009;121(4):18–25
  4. World Health Organization . Medical eligibility criteria for contraceptive use. Reproductive Heath and Research. 4th ed. Geneva: WHO; 2008;
  5. Hohmann H, Creinin MD. The contraceptive implant. Clin Obstet Gynecol. 2007;50(4):907–917
  6. Graesslin O, Korver T. The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care. 2008;13(Suppl 1):4–12
  7. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of implanon. Contraception. 1998;58(Suppl):99S–107S
  8. Simon CS, Kelly L, Singer D. Preventing repeat adolescent pregnancies with early adoption of contraceptive implant. Fam Plann Perspect. 1999;31(2):88–93
  9. Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception. 1986;34:253–260
  10. World Health Organization . Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting. Bull WHO. 1993;71(6):677–689
  11. Rodriguez G, Faundes-Latham A, Atkinson LAN. Approach to analysis of menstrual patterns in the clinical evaluation of contraceptives. Stud Fam Plann. 1976;7:42–51
  12. Altman D. In: Practical statistics for medical research. London: Chapman & Hall; 1991;p. 250
  13. Harvey C, Seib C, Lucke J. Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. Contraception. 2009;80(6):527–532
  14. Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13(Suppl 1):13–28
  15. World Health Organization . Effects of contraceptives on hemoglobin and ferritin. Task Force for Epidemiological Research on Reproductive Health, United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1998;58(5):262–273
  16. Polaneczky M, Slap G, Forke C, Rappaport BS, Sondheimer S. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med. 1994;331:1201–1206

PII: S0010-7824(10)00054-5

doi: 10.1016/j.contraception.2010.02.010

Contraception
Volume 82, Issue 3 , Pages 256-259 , September 2010

Article Tools

* Image Usage & Resolution